SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - North America EU edition | APAC edition

News > Manufacturers

Read more breaking news

 

 

Bog Bilberry recognized as new dietary ingredient for US market

Post a comment
Adi Menayang

By Adi Menayang

30-Aug-2017
Last updated on 30-Aug-2017 at 18:06 GMT2017-08-30T18:06:29Z

Photo: David Gaya/Wikimedia Commons
Photo: David Gaya/Wikimedia Commons

The Food and Drug Administration (FDA) now recognizes bog bilberry, or Vaccinium uliginosum, as a new dietary ingredient for the US market, South Korean manufacturer Dong-A Pharmaceutical announced.

A new dietary ingredient (NDI) notification was originally submitted by Dong-A Pharmaceutical back in December 2015, with the help of a regulatory management consulting firm Ingredient Identity .

"Achieving an NDI status from the FDA validates the safety of the ingredient and will help to greatly expand our business in the United States, specifically in the Dietary Supplement market,” said Yong Sam Kwon, Research Fellow in the Consumer Product Research division of Dong-A Pharmaceutical.

Studies on the extract

The flowering plant, which grows in cool temperate regions of the Northern Hemisphere, has been studied for it antioxidant capabilities, specifically eye and skin health. A search on PubMed revealed that there have been 14 studies in the past 10 years on bog bilberry , seven of which were human studies.

One 2016 study by researchers at Dongguk University found that oral intake of bog bilberry extract for 1000 mg/day for four weeks alleviated eye strain symptoms caused by tablet computer watching. Another study from 2009 found that, in vitro, anthocyanins of bog bilberry extract supported UV-induced skin aging signs.

Currently, up to 500mg/day is the suggested daily usage of bog bilberry deemed safe. “The bog bilberry custom extract is far superior to other conventional bilberry ingredients in the marketplace due to its very unique anthocyanin profile and total polyphenol content, which have been studied extensively in Korea and abroad,” according to the company.

“This success serves as a blue print for many other new ingredients currently in development,” Kwon added. “This NDI status is a great accomplishment given high number of notifications that receive objection letters following the rigorous review process by the FDA."

Post a comment

Comment title *
Your comment *
Your name *
Your email *

We will not publish your email on the site

I agree to Terms and Conditions

These comments have not been moderated. You are encouraged to participate with comments that are relevant to our news stories. You should not post comments that are abusive, threatening, defamatory, misleading or invasive of privacy. For the full terms and conditions for commenting see clause 7 of our Terms and Conditions ‘Participating in Online Communities’. These terms may be updated from time to time, so please read them before posting a comment. Any comment that violates these terms may be removed in its entirety as we do not edit comments. If you wish to complain about a comment please use the "REPORT ABUSE" button or contact the editors.

Related products